Bone Morphogenetic Protein 7 (Human, Recombinant)
CAT:
952-B2010298
Size:
10 µg
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Bone Morphogenetic Protein 7 (Human, Recombinant)
Description:
Bone Morphogenetic Protein 7 (Human, Recombinant)_x000D_ Catalog number: B2010298_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Volume/Weight: 10 ug_x000D_ pH: 7.4 upon reconstitution_x000D_ Supplied as: Lyophilized Powder_x000D_ Appearance: Powder_x000D_ Applications: highly pure Bone Morphogenetic Protein 7 (Human, Recombinant) expressed in E. coli. This protein acts as a member of the BMP-family as well as the transforming growth factor (TGF-β) superfamily with roles in the revision posterolateral lumbar spine fusion._x000D_ Storage: -20C_x000D_ Keywords: rHuBMP-7; OP-1_x000D_ Grade: Biotechnology grade. All components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Dumic-Cule I, Peric M, Kucko L, Grgurevic L, Pecina M, Vukicevic S. Bone_x000D_ morphogenetic proteins in fracture repair. Int Orthop. 2018_x000D_ Nov;42(11):2619-2626._x000D_ _x000D_ 2: Eixarch H, Calvo-Barreiro L, Montalban X, Espejo C. Bone morphogenetic_x000D_ proteins in multiple sclerosis: Role in neuroinflammation. Brain Behav Immun._x000D_ 2018 Feb;68:1-10._x000D_ _x000D_ 3: Krouwels A, Iljas JD, Kragten AHM, Dhert WJA, Öner FC, Tryfonidou MA,_x000D_ Creemers LB. Bone Morphogenetic Proteins for Nucleus Pulposus Regeneration. Int_x000D_ J Mol Sci. 2020 Apr 14;21(8):2720._x000D_ _x000D_ 4: Ueno N, Moos M Jr. Bone morphogenetic proteins. Genes Funct. 1997_x000D_ Dec;1(5-6):287-8._x000D_ _x000D_ 5: Mulloy B, Rider CC. The Bone Morphogenetic Proteins and Their Antagonists._x000D_ Vitam Horm. 2015;99:63-90._x000D_ _x000D_ 6: Carreira AC, Alves GG, Zambuzzi WF, Sogayar MC, Granjeiro JM. Bone_x000D_ Morphogenetic Proteins: structure, biological function and therapeutic_x000D_ applications. Arch Biochem Biophys. 2014 Nov 1;561:64-73._x000D_ _x000D_ 7: Ali IH, Brazil DP. Bone morphogenetic proteins and their antagonists: current_x000D_ and emerging clinical uses. Br J Pharmacol. 2014 Aug;171(15):3620-32._x000D_ _x000D_ 8: Argintar E, Edwards S, Delahay J. Bone morphogenetic proteins in orthopaedic_x000D_ trauma surgery. Injury. 2011 Aug;42(8):730-4._x000D_ _x000D_ 9: Laurencin CT, Lo KW. Bone morphogenetic proteins for bone regeneration and_x000D_ their alternatives. Curr Pharm Des. 2013;19(19):3353._x000D_ 10: Carreira AC, Lojudice FH, Halcsik E, Navarro RD, Sogayar MC, Granjeiro JM._x000D_ Bone morphogenetic proteins: facts, challenges, and future perspectives. J Dent_x000D_ Res. 2014 Apr;93(4):335-45._x000D_ _x000D_ Products Related to Bone Morphogenetic Protein 7 (Human, Recombinant) : ProteinsShort Description:
Catalog Number: B2010298 (10 ug)_x000D_ Bone Morphogenetic Protein 7 (Human, Recombinant) is a high quality research product used as highly pure Bone Morphogenetic Protein 7 (Human, Recombinant) expressed in E. coli. This protein acts as a member of the BMP-family as well as the transforming growth factor (TGF-β) superfamily with roles in the revision posterolateral lumbar spine fusion. Custom bulk orders of this product are available upon request.Weight:
0.15Length:
2Width:
0.5Height :
0.5CAS Number:
9000-83-3